Centene Corporation ($CNC) Stock Forecast: Up 5.1% Today

What is Centene Corporation?

Centene Corporation (CNC) is a healthcare company specializing in government-sponsored healthcare programs for under-insured and uninsured individuals. The company operates through Managed Care and Specialty Services segments.

Why is Centene Corporation going up?

CNC stock is up 5.1% on Jan 6, 2026 14:51

• Centene's stock experienced a 4.2% increase driven by positive developments and analyst upgrades.
• Barclays upgraded Centene's stock rating from "Equal-Weight" to "Overweight" and increased its price target to $54.00 after conducting a detailed pricing analysis of the Affordable Care Act (ACA) market.
• The upgrade reflects confidence in Centene's ability to enhance ACA margins by implementing premium increases while remaining competitive, amidst concerns over ACA premium subsidies.
• The positive sentiment surrounding Centene's stock is also attributed to optimistic forecasts for the Outpatient Clinics Market, suggesting growth opportunities in the healthcare sector that have bolstered investor confidence in the company's future prospects.

CNC Price Chart

CNC Technical Analysis

CNC News

Outpatient Clinics Market Is Going to Boom | HCA Healthcare, Ascension Health, Kaiser Permanente, Mayo Clinic

The Outpatient Clinics Market is projected to grow from USD 102.81 billion in 2025 to USD 150.55 billion by 2032, exhibiting a CAGR of 5.6%. This growth is driven by rapid innovation, increasing investment, and shifting regional dynamics. The report provides key insights into market structure, segment trends, and strategic intelligence for decision-makers.

https://www.openpr.com/news/4337648/outpatient-clinics-market-is-going-to-boom-hca-healthcare

Stanley Laman Group Ltd. Cuts Stake in Elevance Health, Inc. $ELV

Stanley Laman Group Ltd. significantly reduced its stake in Elevance Health, Inc. by 92% in Q3 2025, selling 7,636 shares and ending with 666 shares valued at $215,000. Despite this, major institutional investors like Norges Bank and Vanguard Group continue to hold substantial positions, contributing to an overall institutional ownership of 89.24%. Elevance Health exceeded Q3 expectations with an EPS of $6.03 and 12% revenue growth, offering an annualized dividend of $6.84, yielding approximately 1.9%.

https://www.marketbeat.com/instant-alerts/filing-stanley-laman-group-ltd-cuts-stake-in-elevance-health-inc-elv-2026-01-06/

Advisory Resource Group Increases Stake in Elevance Health, Inc. $ELV

Advisory Resource Group significantly increased its holdings in Elevance Health, Inc. by 43.0% in the third quarter, bringing their total to 18,928 shares valued at $6.116 million. Several other institutional investors also adjusted their positions, contributing to 89.24% institutional ownership of the company's stock. Elevance Health reported strong earnings for the last quarter, surpassing analyst estimates, and has an annualized dividend of $6.84 per share.

https://www.marketbeat.com/instant-alerts/filing-advisory-resource-group-increases-stake-in-elevance-health-inc-elv-2026-01-06/

SEI Investments stock price target raised to $117 by Raymond James By Investing.com

Raymond James has increased its price target for SEI Investments (NASDAQ:SEIC) to $117.00 from $115.00, reiterating an Outperform rating. This adjustment reflects a 34% potential upside from the current price, despite a recent client cancellation in its Private Banks segment. The firm remains confident in SEI's long-term growth due to strong performance in its Investment Managers segment and an attractive risk/reward profile.

https://www.investing.com/news/analyst-ratings/sei-investments-stock-price-target-raised-to-117-by-raymond-james-93CH-4430628

Centene (CNC) Stock Trades Up, Here Is Why

Shares of Centene (NYSE:CNC) rose 4.2% after Barclays upgraded the company's stock from "Equal-Weight" to "Overweight" and increased its price target to $54.00, citing a detailed pricing analysis of the Affordable Care Act (ACA) market. Barclays believes Centene is well-positioned to improve ACA margins through strong premium increases without compromising its competitive standing. This positive sentiment follows a previous drop in the stock due to concerns about the potential non-renewal of ACA premium subsidies.

https://finviz.com/news/267336/centene-cnc-stock-trades-up-here-is-why

Trending Today

Uniswap ($UNI) Crypto Forecast: Down 8.1% Today

Dogecoin ($DOGE) Crypto Forecast: Down 6.4% Today

Algorand ($ALGO) Crypto Forecast: Down 5.3% Today

Silver ($XAG) Commodity Forecast: Down 5.1% Today

Vaulta (prev.EOS) ($A) Crypto Forecast: Down 5.1% Today

ZCash ($ZEC) Crypto Forecast: Down 6.2% Today

Aave ($AAVE) Crypto Forecast: Down 5.3% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 6.9% Today

Blink Charging Co. ($BLNK) Stock Forecast: Down 5.1% Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Down 5.0% Today

Centene Corporation Price History

02.00.2026 - CNC Stock was up 2.3%

• CNC stock witnessed a positive development as Ninety One UK Ltd acquired a new stake in the company, indicating confidence in its future performance.
• The stock's consistent upward trajectory and favorable analyst outlook suggest a reevaluation of risk and a period of accumulation among investors, contributing to its bullish trend.
• CNC's strong Q3 earnings performance, revenue growth, and its exposure to government healthcare initiatives are key drivers of investor confidence and the stock's upward momentum.
• The cautious optimism demonstrated by Wall Street analysts, alongside Centene's strategic portfolio enhancements, are additional factors supporting the bullish momentum of the stock.

05.00.2026 - CNC Stock was up 2.7%

• Upgraded from "Equal-Weight" to "Overweight" by Barclays with a higher price target, suggesting potential margin improvements in the Affordable Care Act (ACA) exchange business.
• Barclays' upgrade, along with optimism regarding CNC's premium increases and competitive positioning, likely drove investor confidence and influenced the bullish market activity.
• Despite prior hurdles, Centene's financial health was rated as "GREAT" by InvestingPro, adding to positive market sentiment.
• The increased investment in Molina Healthcare (MOH) by Merit Financial Group LLC and positive developments in other healthcare companies such as Elevance Health, Inc. may have also contributed to the favorable outlook in the healthcare sector, further boosting CNC's upward movement.

30.09.2025 - CNC Stock was down 5.0%

• The market potentially anticipated stronger earnings and revenue growth, prompting a sell-off post the earnings beat.
• Worries surrounding escalating medical expenses and declining Medicaid memberships might have outweighed the upbeat earnings, triggering a bearish response from investors.
• Traders could have opted for profit-taking after the stock's rise post the positive 2025 forecast, influencing today's bearish trend.

06.00.2026 - CNC Stock was up 5.1%

• Centene's stock experienced a 4.2% increase driven by positive developments and analyst upgrades.
• Barclays upgraded Centene's stock rating from "Equal-Weight" to "Overweight" and increased its price target to $54.00 after conducting a detailed pricing analysis of the Affordable Care Act (ACA) market.
• The upgrade reflects confidence in Centene's ability to enhance ACA margins by implementing premium increases while remaining competitive, amidst concerns over ACA premium subsidies.
• The positive sentiment surrounding Centene's stock is also attributed to optimistic forecasts for the Outpatient Clinics Market, suggesting growth opportunities in the healthcare sector that have bolstered investor confidence in the company's future prospects.

11.11.2025 - CNC Stock was up 8.6%

• CNC stock witnessed a significant bullish trend, which can be attributed to favorable investor sentiment and institutional interest in the company.
• The increased investments from institutional stakeholders such as Amundi and Norges Bank, coupled with optimistic analyst forecasts, drove the upward trajectory of CNC stock.
• Despite potential risks like reimbursement uncertainties and regulatory challenges, the market primarily focused on Centene Corporation's growth potential and strategic investments, fueling the bullish market sentiment.
• While the sale of company shares by a director may have sparked some concerns, overall market dynamics appeared to be more influenced by positive investment trends and Centene Corporation's growth prospects.

16.11.2025 - CNC Stock was down 5.0%

• The bearish movement in Centene Corp. (CNC) stock today could be attributed to several factors:
• Concerns raised by U.S. Senator Marsha Blackburn regarding rising healthcare costs and regulatory violations at CVS Health, which may have sparked worries about potential industry-wide regulatory scrutiny affecting healthcare companies like Centene.
• The ongoing legal battle in Arizona courts over a discrimination lawsuit against Centene, which could be seen as a legal overhang impacting investor sentiment and confidence in the company's operations.
• The broader industry challenges highlighted in the Zacks Industry Outlook for HMOs, indicating a bearish outlook for the sector due to rising medical expenses, regulatory uncertainties, and other headwinds, which may have influenced CNC's stock performance negatively.
• The reduction in stake by National Bank of Canada FI in Elevance Health, Inc. (ELV), a competitor in the healthcare industry, could have also signaled a shift in investor sentiment towards healthcare stocks, potentially impacting CNC's stock price negatively.

11.11.2025 - CNC Stock was up 5.3%

• CNC stock price forecasts are considering Medicaid contract losses and ACA marketplace growth. This optimistic outlook may have influenced today's bullish movement.
• Institutional investors, including Amundi, have been raising their stakes in CNC, showing trust in the company's future performance. This vote of confidence likely improved investor sentiment and contributed to the bullish trend.
• Despite a Director and 10% owner of CNC selling shares, market sentiment remained positive, focusing on favorable investment activities by other institutions.
• Reports of increased investments in other healthcare companies like Molina Healthcare, Inc. (MOH) may have had a positive impact on the healthcare sector, potentially driving the bullish movement in CNC.

10.09.2025 - CNC Stock was down 5.1%

• In contrast to the recent optimism surrounding Centene, the stock witnessed a significant downturn today, potentially signaling a change in market conditions.
• Although the surge in options trading initially boosted investor sentiment, other external factors could have contributed to the sudden drop in stock value.
• Unforeseen events or market pressures may have played a role in the stock's unexpected performance, deviating from the anticipated bullish trend linked to the surge in options trading.

29.09.2025 - CNC Stock was up 12.8%

• CNC's exceptional Q3 earnings outperformed forecasts, driven by strong premium growth and increasing membership in key sectors, which managed to counterbalance higher medical expenses.
• The upbeat 2025 projection from Centene bolstered investor trust, resulting in a rise in the stock value.
• Despite worries surrounding escalating medical expenses and declining Medicaid memberships, Centene's impressive financial results in Q3 provided reassurance to investors about the company's durability.
• The decline in short interest points to an improved market sentiment towards Centene, with fewer investors taking a pessimistic stance on the stock, contributing to its positive momentum.

23.09.2025 - CNC Stock was down 5.4%

• Following an announcement from Molina Healthcare regarding their lower-than-expected annual guidance, Centene's stock price decreased.
• The cautionary statement from Molina Healthcare may have sparked worries among investors regarding the sector's overall performance.
• This development likely eroded confidence in Centene's future earnings potential, prompting investors to sell their shares.
• The bearish movement in Centene's stock today is believed to be influenced by the broader impact of Molina Healthcare's guidance on the healthcare insurance industry.

29.09.2025 - CNC Stock was up 12.1%

• CNC's stock registered a bullish trend today following its stellar Q3 financial performance, exceeding expectations for earnings and revenues.
• The market reacted positively to CNC's recovery from past difficulties, evident in the notable increase in its stock value.
• Despite facing challenges in industry costs, CNC demonstrated strong results, showcasing resilience and growth prospects in the healthcare insurance sector.
• CNC's upward movement was reinforced by a notable drop in short interest, indicating enhanced investor confidence and positivity in the company's outlook.

29.09.2025 - CNC Stock was up 6.1%

• CNC exceeded Q3 earnings and revenue expectations by a significant margin, showcasing robust financial results.
• Despite facing challenges in industry costs, CNC demonstrated effective expense management and achieved positive outcomes.
• The decline in short interest concerning CNC suggests a growing optimistic outlook among investors, contributing to the stock's upward trajectory.
• Even though CNC initially faced a stock decline along with other healthcare providers following Molina Healthcare's underwhelming guidance, CNC rebounded strongly, likely attributed to its strong financial performance and market positioning.